Delivery Order SPE2DX22D0029-SPE2D826F14LT
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,200.68 on January 8, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order will be completed by January 9, 2026, and will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $124,469.46 by the Defense Logistics Agency Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 14, 2026, represents a task order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,783.50 on January 20, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by January 21, 2026, with performance taking place at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,141.37 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and competitively awarded on a firm fixed-price basis, will be completed by January 20, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $3,337.70 on January 9, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a firm fixed-price delivery order with no set-aside designation, has an ultimate completion date of January 12, 2026. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order under...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., has been awarded a delivery order valued at $176,055.90 by the Defense Logistics Agency Medical Supply Chain on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a task order issued under the company's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F14LTDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,876.40 by the Defense Logistics Agency's Medical Supply Chain on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The delivery order supports the Defense Logistics Agency's medical supply operations, which provide critical pharmaceutical products and medical supplies to military healthcare systems worldwide. Amerisourcebergen's extensive federal contract portfolio demonstrates its capability to supply a diverse range of medications and medical commodities, including specialty pharmaceuticals, generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's selection through open competition underscores its qualification to meet federal procurement requirements for essential medical supplies supporting the Department of Defense's healthcare mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/19/26 |